Find Unlimited Emails.For Free.
Discover prospects, find their business emails, and build your pipeline with Unifers.
Start for FreeHarpreet Singh
Board Member (Executive Director) @Immatics
Signup · Get unlimited contacts
WORK HISTORY
Board Member (Executive Director) @Immatics
EDUCATION
University of Tübingen
PhD, Immunology
Technische Universität Darmstadt
Bachelor's degree (Pre-Diploma), Chemistry
University of Tübingen
Master's degree (Diploma), Biochemistry
ABOUT HARPREET SINGH
Dr. Harpreet Singh is Co-Founder, Chief Executive Officer and Member of the Board at Immatics (NASDAQ: IMTX), a clinical-stage biotechnology company and the global leader in precision targeting of PRAME. PRAME is a target expressed in more than 50 cancers and Immatics has the broadest PRAME franchise with the most PRAME indications and modalities, spanning cell therapies and bispecifics.Dr. Harpreet Singh brings together leadership experience, scientific expertise and innovation in T-cell based immunotherapy of advanced solid cancers. He has played a critical role in developing Immatics from a start-up into a global, publicly listed biopharma enterprise, leading a team of more than 500 people based in the US and Germany, committed to making a meaningful impact on the lives of patients with cancer.Dr. Singh holds a PhD in immunology from the University of Tuebingen, Germany.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.